<http://purl.org/spar/fabio/ClinicalTrialDesign> <http://www.w3.org/2000/01/rdf-schema#comment> "A predefined written procedural method, designed to ensure reliability of findings, for undertaking a medical or veterinary clinical study of the safety, efficacy, or optimum dosage schedule of one or more diagnostic, therapeutic or prophylactic drugs or treatments, or of devices or techniques, involving a randomized controlled trial for evidence-based assessment in humans or animals, specifying criteria of eligibility, nature of controls, sampling schedules, data collection parameters, statistical analyses, reporting standards, etc. to be employed in undertaking the clinical trial." <http://purl.org/spar/fabio> .
<http://purl.org/spar/fabio/ClinicalTrialDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.org/spar/fabio> .
<http://purl.org/spar/fabio/ClinicalTrialDesign> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.org/spar/fabio/Specification> <http://purl.org/spar/fabio> .
<http://purl.org/spar/fabio/ClinicalTrialDesign> <http://www.w3.org/2000/01/rdf-schema#label> "clinical trial design"@en <http://purl.org/spar/fabio> .
<http://acm.rkbexplorer.com/ontologies/acm#C.0.1> <http://www.w3.org/2000/01/rdf-schema#label> "C.0.1. Instruction set design" <http://www.rkbexplorer.com/ontologies/acm> .
<http://acm.rkbexplorer.com/ontologies/acm#C.0.1> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://acm.rkbexplorer.com/ontologies/acm#C.0> <http://www.rkbexplorer.com/ontologies/acm> .
<http://acm.rkbexplorer.com/ontologies/acm#C.0.1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.rkbexplorer.com/ontologies/acm> .
<http://acm.rkbexplorer.com/ontologies/acm#C.2.1> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://acm.rkbexplorer.com/ontologies/acm#C.2> <http://www.rkbexplorer.com/ontologies/acm> .
<http://acm.rkbexplorer.com/ontologies/acm#C.2.1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.rkbexplorer.com/ontologies/acm> .
<http://acm.rkbexplorer.com/ontologies/acm#C.2.1> <http://www.w3.org/2000/01/rdf-schema#label> "C.2.1. Network Architecture and Design" <http://www.rkbexplorer.com/ontologies/acm> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://purl.obolibrary.org/obo/IAO_0000111> "comparative genome hybridization by array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_856 comparative_genome_hybridization_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B6c1c3abeb6ef7cf4aad2c30aadd74d9c <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://www.w3.org/2000/01/rdf-schema#label> "comparative genome hybridization by array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001197> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that detects genomic copy number variations using microarray technology."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B628cea35fa0292985c7158977f73a2fe <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://www.w3.org/2000/01/rdf-schema#label> "ChIP-seq design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:Bcc1249fa6e962f5daf4bcf31abb7c3c1 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design which aims to identify protein and DNA interactions using a combination of chromatin immunoprecipitation and high throughput sequencing. Massively parallel sequence analyses are used in conjunction with whole-genome sequence databases to analyze the interaction pattern of any protein with DNA, or the pattern of any epigenetic chromatin modifications."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://purl.obolibrary.org/obo/IAO_0000111> "ChIP-seq design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001258> <http://purl.obolibrary.org/obo/IAO_0000119> "http://en.wikipedia.org/wiki/Chip-Sequencing" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://www.w3.org/2000/01/rdf-schema#label> "clinical history design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_832 clinical_history_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that the organism's clinical history of diagnosis, treatments, e.g. vaccinations, surgery etc. is studied."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B28fde4a81d999e697bdd903f2eeef50c <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://purl.obolibrary.org/obo/IAO_0000111> "clinical history design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001337> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://purl.obolibrary.org/obo/IAO_0000111> "cellular process design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B17a0a5cb38b53cd9762f505f77ca8879 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that aims to study the processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://www.w3.org/2000/01/rdf-schema#label> "cellular process design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001365> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_810 cellular_process_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000125> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000119> "Clinical Research Glossary Version 4.0 CDICS glossary group"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://www.w3.org/2000/01/rdf-schema#label> "clinical study design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000115> "Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods; assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel; dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000111> "clinical study design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000112> "PMID: 17655677.J Cardiovasc Electrophysiol. 2007 Aug;18(9):965-71.Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000116> "The definition needs to be extended to other things than simply patients"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500001> <http://purl.obolibrary.org/obo/IAO_0000117> "PlanAndPlannedProcess Branch"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://purl.obolibrary.org/obo/IAO_0000111> "colocalization identification design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://purl.obolibrary.org/obo/IAO_0000115> "A molecular interaction identification design that investigates the co-occurence and correlation of two or more molecules." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0002590> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://purl.obolibrary.org/obo/IAO_0000119> "url:https://en.wikipedia.org/wiki/Colocalization" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://www.w3.org/2000/01/rdf-schema#label> "colocalization identification design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0002591> <http://purl.obolibrary.org/obo/IAO_0000117> "Rebecca Tauber" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and tiling microarray (chip) assays."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://purl.obolibrary.org/obo/IAO_0000119> "Group: ArrayExpress production team" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://purl.obolibrary.org/obo/IAO_0000111> "ChIP-chip by tiling array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://www.w3.org/2000/01/rdf-schema#label> "ChIP-chip by tiling array design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001417> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000112> "PMID: 17601993-Objective: HIV-infected patients with lipodystrophy (HIV-lipodystrophy) are insulin resistant and have elevated plasma free fatty acid (FFA) concentrations. We aimed to explore the mechanisms underlying FFA-induced insulin resistance in patients with HIV-lipodystrophy. Research Design and Methods: Using a randomized placebo-controlled cross-over design, we studied the effects of an overnight acipimox-induced suppression of FFA on glucose and FFA metabolism by using stable isotope labelled tracer techniques during basal conditions and a two-stage euglycemic, hyperinsulinemic clamp (20 mU insulin/m(2)/min; 50 mU insulin/m(2)/min) in nine patients with nondiabetic HIV-lipodystrophy. All patients received antiretroviral therapy. Biopsies from the vastus lateralis muscle were obtained during each stage of the clamp. Results: Acipimox treatment reduced basal FFA rate of appearance by 68.9% (52.6%-79.5%) and decreased plasma FFA concentration by 51.6 % (42.0%-58.9%), (both, P < 0.0001). Endogenous glucose production was not influenced by acipimox. During the clamp the increase in glucose-uptake was significantly greater after acipimox treatment compared to placebo (acipimox: 26.85 (18.09-39.86) vs placebo: 20.30 (13.67-30.13) mumol/kg/min; P < 0.01). Insulin increased phosphorylation of Akt (Thr(308)) and GSK-3beta (Ser(9)), decreased phosphorylation of glycogen synthase (GS) site 3a+b and increased GS-activity (I-form) in skeletal muscle (P < 0.01). Acipimox decreased phosphorylation of GS (site 3a+b) (P < 0.02) and increased GS-activity (P < 0.01) in muscle. Conclusion: The present study provides direct evidence that suppression of lipolysis in patients with HIV-lipodystrophy improves insulin-stimulated peripheral glucose-uptake. The increased glucose-uptake may in part be explained by increased dephosphorylation of GS (site 3a+b) resulting in increased GS activity."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000119> "(source: http://www.sbu.se/Filer/Content0/publikationer/1/literaturesearching_1993/glossary.html)"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://www.w3.org/2000/01/rdf-schema#label> "cross over design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000111> "cross over design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000115> "a repeated measure design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka *wash-out periods*), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://purl.obolibrary.org/obo/IAO_0000117> "Philippe Rocca-Serra"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500003> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500002> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://www.w3.org/2000/01/rdf-schema#label> "cell cycle design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:Bf070dda969ce5fa4822b47c02cbfa997 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that assays events that occur in relation to the cell cycle, which is the period between the formation of a cell, by division of its mother cell and the time when the cell itself divides to form two daughter cells."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_822 cell_cycle_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001409> <http://purl.obolibrary.org/obo/IAO_0000111> "cell cycle design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that compares samples from different cell components." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_1019 cell_component_comparison_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B3a0809c056fd24d0f3b0cc78b18e4b51 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://purl.obolibrary.org/obo/IAO_0000111> "cell component comparison design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B5cd188c3585a27b67deb9f8a6eabc7fa <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://www.w3.org/2000/01/rdf-schema#label> "cell component comparison design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001205> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://www.w3.org/2000/01/rdf-schema#label> "cell differentiation design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B08d5a6626358278712c9e943f72d7973 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_892 development_or_differentiation_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://purl.obolibrary.org/obo/IAO_0000111> "cell differentiation design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001429> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that assays events associated with cell development or differentiation."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_764 cell_type_comparison_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://purl.obolibrary.org/obo/IAO_0000111> "cell type comparison design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://www.w3.org/2000/01/rdf-schema#label> "cell type comparison design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:Bcae27354c2eb9327694b33d8ebef61b2 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B191d52d4ec8fd8fc45d32c29069d4ec5 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001411> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design that compares cells of different type, for example different cell lines."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://www.w3.org/2002/07/owl#equivalentClass> _:B6b650ea301d2e434458f91af90b3ac93 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0000115> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_555 compound_treatment_design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://www.w3.org/2000/01/rdf-schema#label> "compound treatment design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000111> "compound treatment design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000115> "an intervention design in which the treatment is the administration of a compound" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000116> "This is meant to include all kinds of material administrations, including vaccinations, chemical compounds etc." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000951> <http://purl.obolibrary.org/obo/IAO_0000117> "PERSON: Bjoern Peters" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000119> "MO_933 binding_site_identification_design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0001425> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000118> "ChIP-on-chip design" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000115> "A study design which aims to identify protein binding sites in genomic DNA by a combination of chromatin immunoprecipitation and DNA microarray (chip) assays."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://www.w3.org/2000/01/rdf-schema#label> "ChIP-chip design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000111> "ChIP-chip design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B07901ca918b9f3e679f80273138eee69 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B5bd66e450736c752d32cfa5aba90489d <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://purl.obolibrary.org/obo/IAO_0000117> "Person: Chris Stoeckert, Jie Zheng"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0001403> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <https://w3id.org/arco/ontology/catalogue/iccdNormTag> "ICCD Normativa NU 4.00: DA/DES/DESA; DA/DES/DESM" <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#label> "Raffigurazione su moneta"@it <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#label> "Coin design"@en <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2002/07/owl#disjointWith> <https://w3id.org/arco/ontology/denotative-description/CoinLegend> <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2002/07/owl#versionInfo> "stabile"@it <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <https://w3id.org/arco/ontology/denotative-description> <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2002/07/owl#versionInfo> "stable"@en <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#comment> "This class represents the design on the reverse or the obverse of a numismatic property, as the graphical part of what is represented on a side of a coin, together with the legend (lettering and wording)."@en <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/arco/ontology/denotative-description/AffixedElement> <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/2000/01/rdf-schema#comment> "Questa classe rappresenta la raffigurazione presente sul dritto o sul rovescio di un bene numismatico, intesa come l'insieme degli elementi grafici, che, uniti a una legenda (lettere e parole), fa parte dell'impronta della moneta."@it <https://w3id.org/arco/ontology/denotative-description> .
<https://w3id.org/arco/ontology/denotative-description/CoinDesign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <https://w3id.org/arco/ontology/denotative-description> .
